| scholarly article | Q13442814 |
| P50 | author | Nuo Xu | Q91065540 |
| Yi Cui | Q91065543 | ||
| P2093 | author name string | Mi Zheng | |
| Tianlu Xie | |||
| P2860 | cites work | MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials | Q28077018 |
| Selenium and the course of mild Graves' orbitopathy | Q28238021 | ||
| Epidemiology and prevention of Graves' ophthalmopathy | Q34165523 | ||
| Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves' orbitopathy: A randomized controlled trial | Q34474593 | ||
| Teprotumumab for Thyroid-Associated Ophthalmopathy. | Q34556184 | ||
| Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials | Q34614078 | ||
| Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. | Q35055076 | ||
| Randomized controlled trial of rituximab in patients with Graves' orbitopathy | Q35055124 | ||
| Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone | Q35592595 | ||
| Common Immunosuppressive Monotherapy for Graves' Ophthalmopathy: A Meta-Analysis. | Q35808258 | ||
| The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy | Q36811289 | ||
| Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology | Q37033302 | ||
| Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis | Q37505761 | ||
| Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity | Q37829150 | ||
| Efficacy and safety of orbital radiotherapy for graves' orbitopathy | Q38042043 | ||
| A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy | Q38490904 | ||
| Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy | Q38877933 | ||
| The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy | Q39461693 | ||
| Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy | Q39859345 | ||
| Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study. | Q42476684 | ||
| Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy | Q43055601 | ||
| High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy | Q43583587 | ||
| Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study | Q43705603 | ||
| Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study | Q45161391 | ||
| Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. | Q45173583 | ||
| Potential utility of rituximab for Graves' orbitopathy | Q45719549 | ||
| Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). | Q45852178 | ||
| Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy | Q46585048 | ||
| Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. | Q46748284 | ||
| Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study | Q46784134 | ||
| Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. | Q51258119 | ||
| A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. | Q53359335 | ||
| Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. | Q53758474 | ||
| Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy | Q58109526 | ||
| Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study | Q67876001 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone* | Q70251349 | ||
| Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study | Q70321449 | ||
| Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy | Q71778725 | ||
| Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy | Q72235149 | ||
| Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic | Q72800952 | ||
| Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study | Q73761107 | ||
| Management of exophthalmos and related ocular changes in Graves' disease | Q74338185 | ||
| Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study | Q79546631 | ||
| Colchicine in the treatment of the inflammatory phase of Graves' ophthalmopathy: a prospective and randomized trial with prednisone | Q79712503 | ||
| Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial | Q79775301 | ||
| Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy | Q80293192 | ||
| Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy | Q87422960 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 7184163 | |
| P577 | publication date | 2018-12-12 | |
| P1433 | published in | Journal of Ophthalmology | Q26842872 |
| P1476 | title | Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis | |
| P478 | volume | 2018 |
Search more.